Skip to main content
Livermore
Livermore
ZHEN

Group One Trading, L.P.

SEC CIK
0000932540
Latest filing
Aug 13, 2026

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Group One Trading, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings

Shares (Q2 2026)
85,040
Value
$4.64M
% of portfolio
0.1%
Quarters held
21
Since Q1 2021
Holdings of CRSP by Group One Trading, L.P., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202685,040$4.64M0.1%−10,961−11.4%ReducedHolders
Q1 202696,001$4.57M0.2%+2,047+2.2%AddedHolders
Q4 202593,954$4.93M0.1%−3,288−3.4%ReducedHolders
Q3 202597,242$6.30M0.2%+91,530+1,602.4%AddedHolders
Q2 20255,712$277.8K<0.1%+5,440+2,000.0%AddedHolders
Q1 2025272$9.26K<0.1%−135,011−99.8%ReducedHolders
Q4 2024135,283$5.32M0.2%+42,449+45.7%AddedHolders
Q3 202492,834$4.36M0.2%+24,344+35.5%AddedHolders
Q2 202468,490$3.70M0.1%+44,937+190.8%AddedHolders
Q1 202423,553$1.61M0.1%+23,553NewHolders
Q4 20230$00.0%−63,677−100.0%Sold outHolders
Q3 202363,677$2.89M0.1%−10,362−14.0%ReducedHolders
Q2 202374,039$4.16M0.2%+27,642+59.6%AddedHolders
Q1 202346,397$2.10M0.1%+493+1.1%AddedHolders
Q4 202245,904$1.87M0.1%+39,058+570.5%AddedHolders
Q3 20226,846$447.0K<0.1%−128,901−95.0%ReducedHolders
Q2 2022135,747$8.25M0.2%−89,772−39.8%ReducedHolders
Q1 2022225,519$14.2M0.3%−253,278−52.9%ReducedHolders
Q4 2021478,797$36.3M0.7%+186,961+64.1%AddedHolders
Q3 2021291,836$32.7M0.7%−107,911−27.0%ReducedHolders
Q2 2021399,747$64.7M1.2%+22,853+6.1%AddedHolders
Q1 2021376,894$45.9M1.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.